3'2b transgenic mice have a severe B cell defect, apparently caused by strong feedback inhibition of endogenous H-gene rearrangement coupled with an inability of 3,2b to provide the survival/maturation functions of/~. A unique 3,2b transgenic line, named the C line, was found to permit B cell development. When the C line is crossed with a #-membrane knockout line, 3,2b + B cells develop in the homozygous knockout. In contrast, a transgenic line representative of all the other 3,2b lines is completely B cell deficient when #-mere is deleted. Strikingly, the C phenotype is dominant in C x other 72b transgenic line crosses. There is no evidence for higher 3,2b transgene expression or other position effects on the transgene in the C mouse. The sequences of the three 3"2b transgene copies in the C line are identical to that of the original transgene. These results have led to the conclusion that in the C line the transgene integration constitutively induces a gene whose expression can replace #. To more clearly delineate the stage at which the altered phenotype of the C line is expressed, C mice were crossed onto a X5 knockout background. In the absence of ~,5, the C line produces no B cells. Since it was also found that 3'2b can associate with the surrogate light chain (sL; h5/Vpre-B), the crosses between C line 3'2b mice and ~,5 knockout mice suggest that 3"2b/sL is required for B cell maturation in this mouse line. Thus, 3'2b alone is unable to replace/~ for pre-B cell survival/maturation; however, in combination with an unknown factor and the sL, 3,2b can provide these nurturing functions.
average molecular mass of 35-45 kb. Ligations of digested genomic DNA and BamHI, SmaI double-digested cosmid vector c2RB DNA (12) were performed overnight at 14~ After packaging, the cosmid library was transduced into Escherichia coil strain DH10B (Bethesda Research Laboratories, Gaithersburg, MD). Colony lifts and hybridization was performed essentially as described (13) . Two cosmid clones containing transgene sequences were identified. The pOOH3 and pOOH6 cosmid clones were mapped by Southern analysis in comparison to genomic DNA from C y2b transgenic mice. Subclones were generated by SmaI digestion of the cosmid clones and ligation of the Sinai fragments into the EcoRV site of BluescriptKS + (14) .
Results

The y2b Transgene of the C Line Permits B Cell Development and Suppresses the Synthesis of#.
In other y2b transgenic mice a severe depletion of B cells was seen in spleen and other lymphoid organs (Table 1 343; 3) . In contrast, the C line has only slightly fewer B cells than normal mice (Table 1) . The proportion of B220 + or K + cells is essentially the same as in/z transgenic mice, slightly reduced from those in normal mice. However, most of the peripheral B cells in the C mouse produce 3'2b, 89% of B220 + cells are "y2b +, and only '~17% express #. This is in marked contrast to other ~/2b transgenic mice in which every "y2b + B cell co-expresses/z (Table 1; 3). Thus, whereas normally 3'2b does not permit B cell development and only few pre-B cells mature (those that have managed to rearrange endogenous/~), in the C line B cell development proceeds in the absence of/z expression.
The C'y2b Bone Marrow Contains Maturing B Cells. Analysis of the bone marrow compartment of C ~/2b transgenic mice was performed in order to further characterize B cell development in these mice (15, 16) .
Adult C bone marrow has reduced numbers of lymphoid cells in comparison to normal adult mice. Only 15% of the total nucleated cell population in C bone marrow expresses B220 in comparison to 26% in normal mice (data not shown). However, the distribution and phenotype of cells within the lymphoid compartment of C mice is generally normal (Table  2) , although there seems to be a wide variation in the relative percentages of cells of a given phenotype.
Two populations of B220 + ceils are readily distinguishable within the lymphoid population in normal and C bone marrow. B2201~ cells constitute 38-60% of the lymphoid population in normal bone marrow in comparison to 18-46% of B220 l~ cells in the lymphoid population of C bone marrow (Table 2) . B220 hi cells representing more mature B cells constitute 34-41% of the lymphoid population in the normal bone marrow, and 22--44% in C bone marrow. Within the g § population in the bone marrow, immature B cells can be distinguished by low B220 expression from more mature cells that are B220 hi. FACS | analysis (Becton Dickinson & Co., Mountain View, CA) confirmed that all the B220 hi cells also express mlg (data not shown). The B220 I~ population consists of both mlg-, pre-B cells and immature mlg +, B cells. The percentage of g + cells is similar in normal and C bone marrow (Table 2) . In normal mice, x + cells express/~, whereas in C mice, x + cells are 72b + and only few express endogenous/z.
Thus, the C bone marrow contains a relatively normal distribution of B cell subpopulations. In addition, the phenotype of the emerging B cells is identical to the B cells observed in the spleen. There does not appear to be any perturbation in the ability of developing B cells to progress through the developmental pathway. This distinguishes the C mice from other "y2b lines which exhibit a block within the pre-B cell compartment (3).
Crosses to a tt 7~ansgenic Line Reveal that the C Line Is Capable oflgM Surface Expression. C line mice were crossed to a # transgenic line in order to determine if the C line has an inherent defect in the ability to express membrane IgM. This /x transgenic line exhibits incomplete heavy chain allelic exclusion (3, 9) . FACS | analysis reveals that splenic lymphocytes from C x # double transgenic mice coexpress 72b and transgenic/x at the cell surface (not shown). The lack of endogenous/z (/~b) expression of C mice is maintained in the double transgenics (Table 3) .
The results indicate that C mice can express high levels of mlgM at the cell surface. Thus, they do not have an inherent defect preventing expression ofmlgM. The C lineage seems to be more efficient in promoting heavy chain allelic (3) . In order to determine whether C "y2b transgene expression could functionally subsl;itute for # and rescue B cell development in the 343 lineage, C 72b mice were crossed with 343 72b mice. Analysis of 4-8-wk-old offspring revealed that the C x 343 double transgenic mice are virtually identical to C-only transgenic mice (Fig. 1) 
MU C TRANSGEHIC
~~ G2B C/343 TRAHSGEHIC MU ~~ G2B Figure 1 . FACS | analysis of splenic lymphocytes from adult (C x 343 "r2b) F1 mice. Contour plots depict expression on splenic lymphocytes of #-PE staining on the y-axis and ~2b-FITC staining on the x-axis for representative offspring from a C x 343 "y2b cross. The genotype is indicated within each plot.
# on the cell surface. In addition, the presence of the C transgene in C x 343 double transgenic mice rescues the B cell defect characteristic of 343 "/2b mice (not shown). 46-50% of splenic lymphocytes in C and C x 343 mice in this experiment expressed B220. Only 33% of splenic lymphocytes in 343 mice expressed B220. In addition, bone marrow from C x 343 double transgenic mice exhibits populations of B220 l~ "y2b + and B220 hi, "y2b + cells similar to those observed in C mice, but absent in 343 mice (data not shown).
Thus, the presence of the C ~/2b transgene in 343 transgenic mice can act in a dominant manner to relieve the requirement for endogenous/~ production. The presence of the 343 "y2b transgene copies does not interfere with the generation of mature mlg + B cells when an alternative, functional heavy chain is present.
Expression of'y2b mRNA. Analysis of C x 343 double transgenic mice indicates that cell surface expression patterns of B220 and mlg characteristic of lymphocyte populations in C spleen and bone marrow are dominant (see above). In addition, we wanted to characterize "y2b transcript levels at an early developmental time point as the C and 343 lines exhibit distinct expression levels at this stage. The 343 line expresses high levels of 3'2b in day 12 fetal liver, whereas the C line does not exhibit appreciable 'y2b transcript levels until day 14 (14) . C x 343 double transgenic embryos express high levels of y2b mRNA in fetal liver at day 12 of development ( Fig.  2) . The R.NA expression pattern is identical to that of 343-only transgenic embryos: secreted 3,2b mRNA levels exceed membrane ~/2b mKNA levels which in turn exceed endogenous/~ transcript levels. As in previous analyses, C-only embryos express secreted 72b transcripts at barely detectable levels at day 12, and membrane 3~2b is undetectable at this time. Both "y2b transgenic lines, as well as their double transgenic offspring express levels of # mRNAs similar to normal mice. We presume this to represent mainly sterile # transcripts, but this has not been further investigated.
Thus, whereas C • 343 double transgenic mice show an identical cell surface expression pattern to C lineage mice, embryos exhibit the high 3'2b transcript levels characteristic of 343 lineage mice. To determine if in the bone marrow the expression of the C transgene was favored, bone marrow mRNA from normal, conventional ?2b (343), and C line "y2b transgenic mice was analyzed (Fig. 2 , B and C). Results very similar to the fetal liver were obtained. The conventional "y2b mice produce slightly more 3'2b mRNA of both the membrane and the secreted forms than the C line mice (compare the y2b bands with the actin bands). In both lines again, the secreted form is predominant. These data imply that the dominant C phenotype does not result from higher levels of expression of the transgene. Furthermore, the 343 x C crosses show that the high levels of y2b expression in the 343-1 line are not toxic to B cells.
The C Line Is Capable of Promoting B Cell Development in the Absence of a Functional Endogenous ~ Locus. To defini-
tively determine whether C 72b is fully functional in promoting B cell development, the C 3~2b line was crossed with mice carrying a homozygous deletion of the/~ membrane exons (11) . The ability of C 3~2b transgenic offspring lacking any developmentally functional # gene (C "y2b, #rot-/-) to produce B cells was examined by FACS | analysis of splenocytes (Fig. 3) . Mice of the (C "y2b,/~mt-/-) genotype produce "y2b + -only B cells as efficiently as C y2b littermates carrying one wild-type # locus (C "/2b, #rot+/-). Previously, we performed similar crosses between a # knockout and a/~ transgenic line (3). In the absence of a functional endogenous/~ locus,/~ transgenic mice (/~ +,/zmt-/-) retain the ability to produce a normal composition of splenic lymphocytes (3). Thus, both # and C "y2b transgenes are capable of restoring B cell development in homozygous/~ knockout mice, unequivocally demonstrating the ability of these transgenes to generate all the required signals for proper completion of the B cell developmental pathway. This is in striking contrast to other "y2b transgenic lines which have a complete inhibition of B cell development in a/~mt-/-background (3).
Cosmid Cloning Reveals that the C Line Contains Three Intact, Wild-type Copies of the 72b
Transgene. The characteristics of the C 3'2b mice described so far indicate that whereas the C line has a dominant ability to promote B cell development, this cannot be explained by a dominant (earlier or higher) expression of'y2b in the C line compared with other y2b transgenic lines. This implies that the C 3~2b line possesses some characteristic fundamentally different from other y2b lines. It was possible that a transgene copy in the C line could have sustained a mutation changing the structure and function of the transgene product to become functionally like #. In the course of the analysis of other independent transgenic lines we have found evidence for point mutations and short deletions that likely had occurred before transgene integration (17, 18) .
Thus, the transgenes of the C line were cloned in order to determine if the sequences had been altered. From the initial characterization of the C line we knew that no major deletions or structural alterations had occurred during transgene integration (14) . An integration site map was developed to facilitate identification of each of the three transgene copies. The integration site analysis confirmed the copy number to be precisely three in the C 3'2b lineage, organized as a consecutive array with each copy in the same orientation (14) . The map revealed that the three transgene copies differ at the extreme 5' ends and that two of the copies have incurred small deletions of polylinker sequence. These deletions are minor and do not extend into regulatory or coding regions of the transgene. There is no evidence for deletion of any transgene sequence at the 3' end of any of the copies.
Two overlapping cosmid clones (pOOH3 and pOOH6) containing the entire C transgene array, as well as pieces of flanking DNA from either side of the locus, were isolated (Fig. 4) . Their integrity was confirmed by Southern analysis compared with genomic DNA from C transgenic mice (not shown). The pOOH6 cosmid contains all three transgene copies and "~3 kb of 5' flanking DNA and that of the pOOH3 cosmid contains '~15 kb of 3' flanking DNA, the 3' transgene copy and part of the middle transgene copy extending to a BamHI site in the CH1 domain of the constant region (Fig. 4) .
Individual transgene copies were subcloned and each subclone containing a specific region of the C transgene array was subjected to sequence analysis. The entire coding region sequence of each transgene copy was determined, as well as splice donor and splice acceptor sequences at the borders of each exon, and its respective introns and compared to the published sequence for the BALB/c "y2b locus and the original transgene (not shown) (10, 19) . Several nudeotide substitutions, deletions, and additions were identified in the variable region of all three transgene copies (not shown, but these sequence data are available from EMBL/GenBank/DDBJ under accession number M21294). These nucleotide changes result in alteration of the leader and V region sequence predicted by Tsang et al. (10) . All the nucleotide changes were found to be present in the "y2b plasmid used to create these lines. In addition, sequence analysis of a portion of the variable region DNA from the 343-1 3~2b line confirmed the presence of these mutations. Thus, it seems that all the nucleotide changes observed by sequence analysis of the C transgene copies are accountable as errors in the published sequences.
The cosmid analysis conclusively demonstrates that the C y2b lineage contains three intact and wild-type "y2b transgene copies. Thus the structure of the "y2b transgene product expressed from the C locus cannot be responsible for the unique phenotype that characterizes the C "y2b lineage. This suggests that the integration site may influence the generation of the C-specific phenotype.
Crossing the C Line "y2b Transgene into a A5 Knockout Background Eliminates B Cell Development. Given that the C line can promote B cell development independent of #, it appeared possible that the 3'2b transgene was integrated near and activated a locus which normally was expressed after signaling via the pre-B cell receptor/~/surrogate light chain (sL)L Possible candidate genes could be kinases or other molecules involved in the signaling cascade, perhaps acting independently of the requirement for a functional pre-B cell receptor. To evaluate if a pre-B cell receptor was required for B cell development in the C line, we crossed the 'y2b transgene of the C line (and as a control of the 343-1 'T2b line [3] ) with mice whose )x5 locus was inactivated by homologous recombination (20) .
The results clearly show that no B calls develop in the C transgenic line when X5 is not expressed (Fig. 5 ). The B cell 1 Abbreviation used in this paper: sL, surrogate light chain.
5' Copy
Middle profiles of homozygous ~5 knockout mice with a "~2b transgene are the same regardless of the presence of the C-or the 343-1 3~2b transgenes. Both show essentially no B cells. This suggests that 3/2b in combination with the sL (XS/Vpre-B) is required for B cell development in the C mouse. Normally early pre-B cells do not express 3'2b. The ability of this heavy chain to associate with ~,5 and Vpre-B was assessed by transfecting the transgene into the pre-B cell line 70Z/3 that expresses the sL. Immunoprecipitation of "~2b from 3SS-methionine-labeled cells reveals coprecipitation of two proteins with the expected mobility of the sL X5 and Vpre-B (not shown). In addition, LPS stimulation of these cells results in replacement of the sL by conventional light chain once K expression is induced (Roth, P. E., and A. DeFranco, unpublished results). Thus ~2b heavy chains can physically associate with sL to form a pre-B cell receptor and expression of this receptor is required for complete B cell development in the C line of y2b transgenic mice. 
Discussion
This paper reports the analysis of a unique 3'2b transgenic mouse that has essentially normal B cell development, in contrast to all other 3'2b transgenic mice (3) (4) (5) (6) (Fig. 6 ). The C line is, however, similar to other "/2b transgenic lines in that the "y2b transgene is expressed in fetal liver, bone marrow, and the spleen, and it causes feedback inhibition of endogenous heavy chain gene rearrangement.
"y2b Transgenes Promote Allelic Exclusion of Endogenous Heavy
Chains. All y2b transgenic mice analyzed by us exhibit strong allelic exclusion of endogenous heavy chains (3; this paper). This seems also to be the case for y2b transgenic mice reported by others (5, 6) . The findings with the C mouse support this conclusion: most B cells express 3~2b only, and in crosses with a # transgenic mouse, the expression of endogenous /~ chains is suppressed much more strongly than in the transgehic mice without the 3'2b transgene (Table 3) . Thus, the ability for heavy chain gene feedback is shared by/z, 6 (21), and 3'2b. These three isotypes are closely related in their transmembrane domain and it is possible that the feedback requires that domain. Replacing the transmembrane domain of a "y2b transgene with that of/~ still permits the feedback inhibition, but does not restore the B cell maturation defect of y2b mice (3).
B Cell Development Is Similar in C T2b Transgenic Mice to /~ Transgenic Mice. B cells expressing mlg accumulate some-
what more slowly in C transgenic mice than in normal mice. This is similar to the reduction seen in the 243-4 # transgenic line examined in comparison to the C line (Table 1) . Other studies (22) (23) (24) (25) have also shown that Ig transgenic mice exhibit a reduction in the size of their B cell population, although the severity of the depletion varies. In addition to the variability in B cell populations between different transgenic lines, there is variability in the level of feedback regulation resulting in allelic exclusion in different transgenic lines.
The C line exhibits stronger allelic exclusion than the 243-4 # line (Table 3) . However other/z transgenic lines have been shown to exhibit a similar degree of allelic exclusion as the C line (26, 27) .
A large proportion of y2b/v double-producing B cells is seen in the spleen of/~-x 3,2b-transgenic crosses. This suggests that selection against cells which produce two heavy chains is not automatic. (It may of course play a role in antigenspecific tolerance). Furthermore, feedback inhibition of H-gene rearrangement by "y2b heavy chains clearly is very significant (Table 3) . Taken together, these results further support the existence of heavy chain feedback, rather than selection, as the major mechanism for heavy chain allelic exclusion (28) .
Why is the C Mouse Able to Promote B Cell Development?
The findings presented here show that the C line differs from all other ~2b transgenic lines (3-6) in its permissiveness orB cell development. Most B cells in the C line express y2b only, the C line transgene can rescue the B cell defect of another 3'2b transgenic line, and C line B cells develop in the absence of/z expression in a/z knockout background.
What is the molecular basis for the unique phenotype in the C y2b transgenic line? Below we summarize the mechanisms by which the 3~2b transgene in the C line could affect B cell development. An important basis for our conclusions is the dominance of the C phenotype in crosses with another 3~2b transgenic line.
(a) It is unlikely that the C effect is due to inactivation of an endogenous gene, since the effect is dominant. The transgene has been carried as a hemizygous integration for many years, thus a normal locus would always be present. The C phenotype is also independent of the sex of the parent transmitting the transgene, indicating that the normal locus cannot be inactivated by parental imprinting.
(b) The integration of the y2b transgene in the C line does not qualitatively nor quantitatively change the expression of qr2b compared to other 3'2b transgenic lines in a way that can explain the phenotypic differences. Since the C phenotype is dominant, a position effect would have to express itself in a positive way, such as earlier or stronger expression or an increase in the membrane form of the 3~2b mRNA. Comparing 3r2b expression in transgenic lines shows that the expression of 3'2b is somewhat weaker and slightly delayed in the C line (Fig. 3) . Furthermore, the ratio of membrane to secreted 3'2b mRNA is shifted in favor of the secreted form in both lines of 3r2b transgenic mice (Fig. 3) . Finally, in crosses between the C and 343-1 3~2b transgenic lines, the mRNA profile of the double transgenic is identical to that of the conventional 3'2b line (343), whereas B cell development proceeds identically to the C line.
Furthermore, different 3'2b transgenics express different levels of 'y2b (3). The expression in the C mouse seems to be between the two extremes, the 343 and 348A mice, in level and timing. The 343 mice have the strongest feedback effect and the lowest number of B cells in young mice, whereas the 348A mice have the least feedback and the highest number of B cells. Nevertheless, both 343 and 348A express/x on all B cells, in marked contrast to the C line. It appears thus very unlikely that the expression pattern of the 'y2b transgene itself is responsible for the B cell developmental effect seen in the C line.
(c) A third possibility seemed that the transgene in the C line might be altered in a way that would allow it to mimic /x during B cell development. However, as shown, the three transgene copies in the C line are identical to those in the other three 3'2b transgenic lines produced in our laboratory (3, 10) .
(d) This leaves the possibility that the transgene integration site itself mediates the phenotype observed in the C line. Transgene expression is regulated by the strong heavy chain intronic enhancer. Essentially all transgenic mice with transgenes regulated by this enhancer express the transgene regardless of chromosomal integration site (2). It is possible that an endogenous locus is coordinately activated with the "y2b transgene due to the insertion of the heavy chain enhancer. This is analogous to B cell neoplasias associated with translocation or mutation events resulting in alterations in expression patterns of normal cellular genes (29) .
Since the original founder mouse was a (C57BL/6 x SJL)Fz, the possibility existed that the transgene in the C mouse was integrated in a SJL-derived chromosome retained despite the backcrossing to C57BL/6. The difference to the conventional transgenics could have been due to maintenance of this SJL component in the C mouse. However, crossing of the conventional 3'2b mouse lines, 343 and 348A, with SJL did not result in a C phenotype (Kurtz, B., and U. Storb, unpublished observations).
One of the functions of/x appears to be the upregulation of light chain gene rearrangement in pre-B cells, although a basal level of light chain rearrangement does not require /z (20, (30) (31) (32) . We previously investigated the possibility that y2b was unable to upregulate light chains. That analysis indicated that the B cell defect observed in 3'2b transgenic mice was not alleviated when the 343-1 3'2b line was crossed with a )x transgenic line (3). The )~ transgene in that analysis is regulated by the heavy chain enhancer and should therefore be expressed early enough to provide high levels of light chains (33) . Furthermore, in fetal liver and bone marrow of the 343-1 3'2b line, the levels of endogenous r mKNA appear to be normal (3) . In the C line too, there does not appear to be any change in the timing or level of expression of endogenous r (14) . Additionally, we have localized the integration site of the transgene to chromosome 13 (Kurtz, B., A. Fernald, M. LeBean, and U. Storb, unpublished results), thus it cannot directly affect either r (chromosome 6) or X (chromosome 16) light chain genes. Taken together, these results make it unlikely that the phenotype in the C line results from transgene insertion activating either of the endogenous light chain loci.
The Requirement for It May be Circumvented in the C y2b
Transgenic Line by Intersection of Signaling Pathways. Since all other possibilities appear unlikely, we postulate that a protein, which is not a light chain, is produced in the C line, and that expression of this protein during B cell development can overcome the block normally seen in 3'2b transgenic mice. This protein would presumably be produced by a gene activated by the heavy chain enhancer in the transgene. Since # is not required for B cell development in the C line, presumably a signal must be generated that circumvents/z. The signals generated by # apparently operate through the pre-B cell receptor in combination with the sL, X5 and Vpre-B (16, 20) . Thus, circumventing the signal could occur at several levels, namely, the pre-B cell receptor itself, a ligand for the receptor, or a downstream event within the signaling cascade of the pre-B cell receptor. However, a downstream event could not act autonomously, since the crosses with the X5 knockout mice indicate that signaling through a pre-B cell receptor is required for B cell development in the C line. Unless X5 has an as yet unknown function, that is independent of the pre-B cell receptor, the lack of B cells in the X5 knockout mice that carry the C "/2b transgene suggests that 3'2b has a signaling role in B cell development in the C line and that 3'2b functions in association with X5. Consistent with this is the finding that the ~/2b heavy chain expressed in these transgenic mice can associate with the X5 and Vpre-B chains when transfected into a sL positive cell line.
Why, if a sL complex is required for B cell development in the C line, do other y2b transgenes not promote development? Apparently, a 3,2b/sL receptor is not sufficient to drive B cell development (Fig. 7 ). An additional function is required and the C 3'2b line is unique among 3'2b transgenic lines in being able to provide this signal. The postulated gene activated in the C line is unlikely to participate in an event upstream to the expression of 3'2bAL since B cell development arrests at the same (3, 20) or slightly later (Kurtz, B., and U. Storb, unpublished observations) pre-B cell stage in conventional 3'2b transgenic lines compared to the X5 knockout mice. Thus the function of the unknown gene in the C line is either coincident with the 3'2b/sL signal, or is a downstream event induced by the y2b/sL signal.
A complex signal may be generated by the/z/sL, but only a partial signal by the y2bAL. Indeed, #, in association with Another possibility for the postulated gene product activated in the C line may be a ligand for the 3,2b/sL receptor. This could be either a molecule present in other cells in the bone marrow or a protein induced within the pre-B cell after receptor assembly. Other cells interacting with pre-B cells that could express the qr2b/sL receptor ligand could be stromal or T cells. However, the effect is unlikely to be due to stromal cells since the C phenotype can be adoptively transferred to irradiated mice (Roth, P. E., and U. Storb, unpublished results). The bone marrow recipients produce "y2b-only B cells and it is not likely that stromal cells have been preserved in the transferred cells.
T cells, however, could express the postulated gene activated in the C line. T cells are known to transcribe heavy chain transgenes under the control of the heavy chain intronic enhancer (2). However, T cells are apparently not required for normal B cell development since introduction of transgenic heavy and light chain genes into recombination activating gene (RAG) knockout mice, which lack T cells, is sufficient to allow B cell development (35, 36) . Expression of different factors can influence pre-B cell growth and differentiation, thus it remains a formal possibility that a gene functioning in T cells could be activated in the C line to promote B cell development.
An additional possibility is that the postulated gene is expressed within pre-B cells in a post pre-B cell receptor function. As discussed, it seems likely that the 3,2bAL receptor provides only a subset of the signals generated by a ~AL receptor. Thus, activation ofa gene that is normally a downstream target of pre-B cell receptor signaling could compensate for the missing signal. It is also possible that the activated gene does not normally function during B cell development, but can substitute for the missing signal when ectopically expressed. Indeed, functional redundancy has been demonstrated in TCR signaling. For example, increased expression of either the T cell-specific isoform of p59f~, (fyn T), or the alternative isoform prevalent in brain, (fyn B), results in improved responsiveness to TCR stimulation demonstrating that fyn B can substitute for fyn T (37).
Finally, another potential function of the postulated gene activation event in the C line could be to promote cell survival. Genes such as Bcl-2, can promote cell survival and block induction of apoptosis (38--40) . In addition, Bcl-2 and its partner, Bcl-x, do not reside on chromosome 13 (the site of the C transgene integration), but on chromosome I (41) and 2 (Thompson, C., personal communication), respectively, making it unlikely that these genes are specifically involved in mediating B cell development in the C line. It remains possible that as yet unknown genes can mediate pre-B cell survival. Perhaps one of the functions of signaling through the pre-B cell receptor is to induce cell survival or progression through the cell cycle to expand developing pre-B cells with functional heavy chain gene rearrangements. Developing pre-B cells have a finite life span and in the absence of appropriate signals it is likely that these cells apoptose in the bone marrow (42, 43) . A failure of ~/2b to promote cell survival is consistent with the severe B cell defect observed in most 3'2b transgenic mice (3). Thus, activation of a gene involved in cell survival or cell cycle progression could mediate the phenotype characteristic of the C line. It is important to note however, that signaling through the qr2bAL receptor is required either to activate this gene or in addition to activation of this gene to render the cells susceptible to its activity.
In summary, we present the characterization of a unique "y2b transgenic line. Unlike all other "r2b transgenic lines, the C line produces B cells expressing only 3'2b heavy chains. We have shown that this phenotype is mediated neither by a unique expression pattern of the C transgene, nor by an alteration of the transgene itself. We postulate instead that 'y2b, in combination with the sL and an unknown factor, can replace/~ in B cell development (Fig. 7) . The precise mechanism promoting B cell development in this unique line has not been fully elucidated. We offer several possibilities for functions that could be activated in the C line. Most of these possibilities can be tested experimentally. These studies reiterate the complexity of requirements for proper B cell development. The production of a functional heavy chain mediates progression through the developmental pathway, but it is clear from these studies that multiple signals are required to complete this pathway. It is hoped that this unique line will lead to new insights into the signals necessary for B cell development.
